AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 173 filers reported holding AXSOME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $372,163 | -53.0% | 5,179 | -59.6% | 0.03% | -35.4% |
| Q1 2023 | $791,601 | -17.9% | 12,834 | +2.6% | 0.05% | -25.0% |
| Q4 2022 | $964,588 | +54.8% | 12,506 | -10.4% | 0.06% | +56.1% |
| Q3 2022 | $623,000 | -8.7% | 13,962 | -21.6% | 0.04% | +13.9% |
| Q2 2022 | $682,000 | +0.9% | 17,809 | +9.0% | 0.04% | +2.9% |
| Q1 2022 | $676,000 | +27.8% | 16,344 | +16.7% | 0.04% | +9.4% |
| Q4 2021 | $529,000 | +65.3% | 14,009 | +44.4% | 0.03% | +77.8% |
| Q3 2021 | $320,000 | -62.9% | 9,700 | -24.1% | 0.02% | -60.9% |
| Q2 2021 | $862,000 | +42.7% | 12,772 | +19.8% | 0.05% | +35.3% |
| Q1 2021 | $604,000 | +9.6% | 10,661 | +57.7% | 0.03% | -15.0% |
| Q4 2020 | $551,000 | -74.1% | 6,760 | -77.3% | 0.04% | -42.0% |
| Q3 2020 | $2,126,000 | -7.8% | 29,842 | +6.4% | 0.07% | +15.0% |
| Q2 2020 | $2,307,000 | +33.9% | 28,035 | -4.3% | 0.06% | +33.3% |
| Q1 2020 | $1,723,000 | -92.7% | 29,289 | -87.1% | 0.04% | -86.4% |
| Q4 2019 | $23,517,000 | – | 227,526 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 758,794 | $53,032,113 | 65.14% |
| Fairmount Funds Management LLC | 2,341,238 | $163,629,124 | 19.69% |
| Ally Bridge Group (NY) LLC | 110,600 | $7,729,834 | 9.07% |
| RTW INVESTMENTS, LP | 4,489,596 | $313,777,864 | 6.62% |
| SVB FINANCIAL GROUP | 33,849 | $2,365,707 | 4.45% |
| BVF INC/IL | 2,131,100 | $148,942,579 | 4.02% |
| Altium Capital Management LP | 92,000 | $6,429,880 | 3.35% |
| Tri Locum Partners LP | 142,510 | $9,960,024 | 3.18% |
| TANG CAPITAL MANAGEMENT LLC | 320,000 | $22,364,800 | 3.16% |
| Deep Track Capital, LP | 1,140,745 | $79,726,668 | 3.08% |